V. Smit

发表

Validity of a two-antibody testing algorithm for mismatch repair deficiency testing in cancer; a systematic literature review and meta-analysis

J. Goeman, H. Morreau, T. Bosse, 2022, Modern Pathology.

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

H. Putter, W. V. Putten, R. Nout, 2010, The Lancet.

Vaginal brachytherapy versus external beam pelvic radiotherapy for high-intermediate risk endometrial cancer: Results of the randomized PORTEC-2 trial

H. Putter, I. Jürgenliemk-Schulz, A. Slot, 2008 .

L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results.

T. Bosse, V. Smit, I. Jürgenliemk-Schulz, 2014, European journal of cancer.

Validity of a two-antibody testing algorithm for mismatch repair deficiency testing in cancer; a systematic literature review and meta-analysis

J. Goeman, H. Morreau, T. Bosse, 2022, Modern Pathology.

Intraplacental choriocarcinoma as an unexpected cause of intrauterine death at term

F. Vandenbussche, M. Wasser, A. Peters, 2007, International Journal of Gynecologic Cancer.

Immunohistology of a sarcomatous mural nodule in an ovarian mucinous cystadenocarcinoma.

J. Bruijn, G. J. Fleuren, V. Smit, 1987, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Linking uterine serous carcinoma to BRCA1/2-associated cancer syndrome: A meta-analysis and case report.

O. Dekkers, C. Asperen, C. V. van Asperen, 2017, European journal of cancer.

Acute pancreatitis in systemic lupus erythematosus.

G. A. van Albada-Kuipers, J. Bruijn, F. Eulderink, 1986, Scandinavian journal of rheumatology.

Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer

H. Putter, C. Haie-meder, D. Katsaros, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy

H. Putter, T. Bosse, B. van Triest, 2018, British Journal of Cancer.

Practical guidance for mismatch repair-deficiency testing in endometrial cancer

H. Morreau, T. van Wezel, T. Bosse, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Practical guidance for mismatch repair-deficiency testing in endometrial cancer.

H. Morreau, T. van Wezel, T. Bosse, 2017 .

Rheumatoid vasculitis presenting as appendicitis.

J. V. van Laar, F. Breedveld, G. Collée, 1998, Clinical and experimental rheumatology.

Nuclear β‐catenin is a molecular feature of type I endometrial carcinoma

C. Creutzberg, L. C. van den Broek, V. Smit, 2003 .

Combined E-cadherin, alpha-catenin, and beta-catenin expression is a favorable prognostic factor in endometrial carcinoma.

A. Scholten, C. Creutzberg, R. Aliredjo, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Combined E-cadherin, α-catenin, and β-catenin expression is a favorable prognostic factor in endometrial carcinoma

A. Scholten, C. Creutzberg, R. Aliredjo, 2004, International Journal of Gynecologic Cancer.

Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries.

G. Fleuren, C. V. D. van de Velde, J. Hermans, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

5000 ORAL Quality of life after radiotherapy for endometrial cancer: first results from the randomized PORTEC-2 trial

H. Putter, R. Nout, A. Slot, 2007 .

Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma.

E. Noordijk, A. Scholten, C. Creutzberg, 2003, The Journal of pathology.

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy

T. Bosse, B. van Triest, W. van Putten, 2018, British Journal of Cancer.

595 Implementation of collaborative translational research (TransPORTEC) findings in an international endometrial cancer clinical trials program (RAINBO)

T. Bosse, L. Mileshkin, N. Horeweg, 2021, Endometrial cancer.

An uncommon cause of stroke in young adults.

B. Bloem, G. Lammers, V. Smit, 1999, Archives of neurology.

OC-0369: Long-Term Quality of Life after (chemo)radiotherapy for high-risk Endometrial Cancer in PORTEC-3

H. Putter, D. Katsaros, J. Ledermann, 2020 .

New mutations in two Dutch patients with early infantile galactosialidosis.

J. Groener, A. d’Azzo, P. Maaswinkel-Mooy, 2003, Molecular genetics and metabolism.